InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
Normocin® - Antimicrobial Reagent | Skin-targeted delivery of extracellular vesicle-encapsulated curcumin using d... | 2022 | Acta Biomater. | Yerneni S.S. et al. | DOI: 10.1016/j.actbio.2022.06.046 |
ODN 1826 VacciGrade™ | A third vaccination with a single T cell epitope confers protection in a muri... | 2022 | Nat Commun | Pardieck I.N. et al. | DOI: 10.1038/s41467-022-31721-6 |
THP1-Dual™ Cells | Recognition of HIV-1 capsid by PQBP1 licenses an innate immune sensing of nas... | 2022 | Mol Cell | Yoh S.M. et al. | DOI: 10.1016/j.molcel.2022.06.010 |
THP1-Dual™ KO-cGAS Cells | Recognition of HIV-1 capsid by PQBP1 licenses an innate immune sensing of nas... | 2022 | Mol Cell | Yoh S.M. et al. | DOI: 10.1016/j.molcel.2022.06.010 |
2'3'-cGAMP | Recognition of HIV-1 capsid by PQBP1 licenses an innate immune sensing of nas... | 2022 | Mol Cell | Yoh S.M. et al. | DOI: 10.1016/j.molcel.2022.06.010 |
LPS-EB VacciGrade™ | Effects of the combination of a monoclonal agonistic mouse anti-OX40 antibody... | 2022 | PLoS One | Gulyás D. et al. | DOI: 10.1371/journal.pone.0270802 |
PGN-BS peptidoglycan preparation | Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody pro... | 2022 | J Autoimmun. | Ning W. et al. | DOI: 10.1016/j.jaut.2022.102860 |
PGN-SA peptidoglycan preparation | Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody pro... | 2022 | J Autoimmun. | Ning W. et al. | DOI: 10.1016/j.jaut.2022.102860 |
Mouse TLR2 Reporter HEK293 Cells (NF-κB) | Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody pro... | 2022 | J Autoimmun. | Ning W. et al. | DOI: 10.1016/j.jaut.2022.102860 |
Mouse Control IgG2a | Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody pro... | 2022 | J Autoimmun. | Ning W. et al. | DOI: 10.1016/j.jaut.2022.102860 |
Anti-mTLR2 Detection and Neutralizing mAb | Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody pro... | 2022 | J Autoimmun. | Ning W. et al. | DOI: 10.1016/j.jaut.2022.102860 |
pCpGfree-promoter | Identification of TMEM129, encoding a ubiquitin-protein ligase, as an effecto... | 2022 | Arthritis Res Ther. | Brumwell A. et al. | DOI: 10.1186/s13075-022-02882-y |
Alhydrogel® adjuvant 2% | Virus-like particles displaying conserved toxin epitopes stimulate polyspecif... | 2022 | Sci Rep. | Menzies S.K. et al. | DOI: 10.1038/s41598-022-13376-x |
NLRP3 inflammasome inhibitor - MCC950 | Dehydroisohispanolone as a Promising NLRP3 Inhibitor Agent: Bioevaluation and... | 2022 | Pharmaceuticals (Basel) | González-Cofrade L. et al. | DOI: 10.3390/ph15070825 |
Protein L / Agarose | Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as a... | 2022 | Nat Biomed Eng. | Wang Z. et al. | DOI: 10.1038/s41551-022-00902-5 |
Human ACE2 & TMPRSS2 expressing A549 Cells | Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as a... | 2022 | Nat Biomed Eng. | Wang Z. et al. | DOI: 10.1038/s41551-022-00902-5 |
LyoVec™ | Pacritinib Inhibition of IRAK1 Blocks Aberrant TLR8 Signalling by SARS-CoV-2 ... | 2022 | J Innate Immun. | Campbell G.R. et al. | DOI: 10.1159/000525292 |
SARS-CoV-2 Spike S1 Proteins | A Biosensor Platform for Point-of-Care SARS-CoV-2 Screening. | 2022 | Biosensors (Basel) | Georgas A. et al. | DOI: 10.3390/bios12070487 |
Human ACE2 Protein | A Biosensor Platform for Point-of-Care SARS-CoV-2 Screening. | 2022 | Biosensors (Basel) | Georgas A. et al. | DOI: 10.3390/bios12070487 |
Pepinh-TRIF | Activation of TLR-pathway to induce host Th1 immune response against visceral... | 2022 | Heliyon | Pradhan S. et al. | DOI: 10.1016/j.heliyon.2022.e09868 |